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Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micro-
gnathia, temporomandibular joint ankylosis, cleft palate, and a characteristic ‘‘question-mark’’ ear malformation. Careful phenotypic
characterization of severely affected probands in our cohort suggested the presence of a mandibular patterning defect resulting in
a maxillary phenotype (i.e., homeotic transformation). We used exome sequencing of five probands and identified two novel (exclusive
to the patient and/or family studied) missense mutations in PLCB4 and a shared mutation in GNAI3 in two unrelated probands. In
confirmatory studies, three additional novel PLCB4 mutations were found in multigenerational ACS pedigrees. All mutations were
confirmed by Sanger sequencing, were not present in more than 10,000 control chromosomes, and resulted in amino-acid substitutions
located in highly conserved protein domains. Additionally, protein-structure modeling demonstrated that all ACS substitutions disrupt
the catalytic sites of PLCB4 and GNAI3. We suggest that PLCB4 and GNAI3 are core signaling molecules of the endothelin-1-distal-less
homeobox 5 and 6 (EDN1-DLX5/DLX6) pathway. Functional studies demonstrated a significant reduction in downstream DLX5 and
DLX6 expression in ACS cases in assays using cultured osteoblasts from probands and controls. These results support the role of
the previously implicated EDN1-DLX5/6 pathway in regulating mandibular specification in other species, which, when disrupted,
results in a maxillary phenotype. This work defines the molecular basis of ACS as a homeotic transformation (mandible to maxilla)
in humans.Auriculocondylar syndrome (ACS; MIM 602483; also
known as ‘‘question-mark ear syndrome’’ or ‘‘dysgnathia
complex’’) is an autosomal-dominant craniofacial mal-
formation syndrome characterized by highly variable
mandibular anomalies ranging from mild to severe micro-
gnathia, often with temporomandibular joint (TMJ) anky-
losis, cleft palate, and a distinctive ear malformation that
consists of separation of the lobule from the external ear,
giving the appearance of a question mark (Figure 1). Other
frequently described features include prominent cheeks,
cupped and posteriorly rotated ears, preauricular
tags, and microstomia. ACS was first described in a mother
and her two affected children just over thirty years ago,1
and nine well-characterized families withmultiple affected
individuals2–8 (and at least one linkage peak mapping to
1p21-1q236,9) as well as several simplex cases4,10–12 have
been reported to date.
Our index case (S011) and her affected mother
(S012P; kindred D, individuals I-1 and II-1, respectively,
in Figure S1, available online) had severe mandibular
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The Amlateral fusion of the mandible to the temporozygomatic
suture and medial fusion to the skull base (medial and
lateral pterygoid plates) (Figure 2), resulting in airway
obstruction requiring tracheostomy. Intraoperative evalua-
tion of S011 was notable for the presence of severe micro-
glossia, elongated soft-tissue masses attached at the poste-
rior floor of themouth, and excessive soft tissue protruding
from the medial alveolus of the lower jaw, giving the
appearance of a ‘‘mandibular palate’’ (Figure 2). We identi-
fied four additional kindreds with dysgnathia complex
(i.e., ACS),3 as well as two simplex case child-parent trios
(S001 and S008 [II-1 individuals in kindreds B and C,
respectively, in Figure S1]), a family with two affected
siblings (S004 [proband] and S005 [kindred A, individuals
II-1 and II-2 in Figure S1]) whose father had mild mandib-
ular hypoplasia, and an additional singleton proband
(A001; Figure S1). We obtained approval for this study
from our institutional review board (Seattle Children’s
Hospital), written consent was obtained for all partici-
pants, and consent for photography was obtained from
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Figure 2. Homeotic Transformation of the Mandible to a
Maxillary Phenotype
(A) Microglossia and lateral soft-tissue projections at the tongue
base as seen intraoperatively in our index case S011 (GNAI3
p.Gly40Arg).
(B) Excessive soft-tissue projections emanating from the medial
surface of the lower jaw.
(C) 3D CT demonstrates severe mandibular hypoplasia, with
fusion of the lateral mandibular process to the temporozygomatic
suture (red arrow).
(D) Medial view of a parasagittal section of the skull reveals
complete fusion of the left mandibular ramus with the medial
and lateral pterygoid plates (within red dashed circle); inset depicts
the plane of the section.
(E) Control CT image of an age- and sex-matched individual
showing normal mandible anatomy.
(F) CT image of individual S001 with a PLCB4 p.Tyr623Cys substi-
tution.
(G) A composite CT image generated with photo-editing software
in which the mandible from panel F was copied, inverted, and
placed over the control maxilla in panel G. The resultant image
shown here depicts the remarkable alignment of the ACS
mandible with the control maxilla, zygomatic arch, and midfacial
structures, demonstrating transformation to a maxillary identity
(a homeotic transformation).
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Figure 1. PLCB4 and GNAI3 Mutations Lead to Severe Mandib-
ular Hypoplasia and Ear Dysplasia
(A) Facial photos of proband S001 (PLCB4 p.Tyr623Cys)
(B) S008 (GNAI3 p.Gly40Arg) with severe micrognathia and the
classic ‘‘questionmark’’ ear (inset). Below each photo is the respec-
tive three-dimensional computed tomography (3D CT) scan,
which shows the severe mandibular hypoplasia associated with
mandibular body and ramus dysplasia.manuscript. In each case, mandibular ankylosis was pro-
gressive, of variable severity, and characterized by incon-
sistent fusion to the medial and lateral pterygoid plates.
All cases demonstrated a similar phenotype, consisting of
a lateral mandibular bony prominence with or without
TMJ ankylosis, and had features consistent with classic
ACS. The anatomic features of these cases led us to hypoth-
esize that the malformations observed in individuals
with ACS were due to a homeotic transformation, with
the mandible assuming a maxillary phenotype (Figures
2E–2G).
Other reports of mandibular patterning mutations in
mice and zebrafish have implicated the endothelin-1
(EDN1) receptor A (EDNRA) and its downstream targets,
distal-less homeobox 5 and 6 (DLX5 and DLX6).13–16
Sanger sequencing of endothelin-1 pathway candidates
EDNRA, DLX5, and DLX6 in our probands was negative.
We performed exome sequencing on all five probands
and parents (excluding A001 [no parental DNA available]
and S012-P [inadequate sample]) to identify gene-based
coding variants present in individuals with ACS. Genomic
libraries were prepared and underwent exome capture with
the use of a 28 Mb target derived from the consensus
coding sequence (CCDS) database (version 20080902)17
or the ~32 Mb target from Roche Nimblegen SeqCap EZ
(version 1.0). Exome-enriched libraries were sequenced
on Illumina GAIIx or HiSeq 2000 platforms with paired-
end 50 or 76 base reads. Each individual generated ~75
million unique reads mapping to the exome target and
nearby flanking regions. Over 93% of the exome positions908 The American Journal of Human Genetics 90, 907–914, May 4, 2had a coverage depth > 83, and the average overall
coverage depth was 1033. Data from each individual
were processed from real-time base calls and aligned to a
human reference (hg19) through the use of the Burrows-
Wheeler Aligner.18 Data was processed with the use of
the Genome Analysis Toolkit19 (GATK reference version
1.0.2905), and variant detection and genotyping were per-
formed with the use of the Unified Genotyper (GATK) tool.
We flagged variant sites by using the filtration walker
(GATK) to mark sites that were of lower quality and more
likely to be false positives. Each individual generated an012
Table 1. PLCB4 and GNAI3 Mutations in Probands with Auriculocondylar Syndrome
Individual/ Pedigree Gene Amino Acid Nucleotide GERP GS Control Frequency Inheritance
S001 PLCB4 Tyr623Cys c.1868A>G 6.17 194 0/10758 de novo
S004a PLCB4 Asn329Ser c.986A>C 5.93 46 0/10758 transmitted (IPb)
M001 PLCB4 Arg621His c.1862G>A 6.17 29 0/10758 transmitted
M002 PLCB4 Asn650His c.1948A>C 5.92 68 0/10758 transmitted
M003 PLCB4 Arg621Cys c.1861C>T 6.17 180 0/10758 transmitted (IPb)
S008, S011 GNAI3 Gly40Arg c.118G>C 5.82 125 0/10758 transmitted
Exome sequencing and Sanger confirmation identified five missense mutations that lead to rare substitutions in the catalytic domain of PLCB4 in five families and
a single GNAI3 catalytic domain substitution in two unrelated families. These mutations are in highly conserved domains as indicated by GERP score and Grantham
score (GS), and they are not found in a control set of human exomes from the NHLBI ESP data release ESP5400, accessed on December 10, 2011. M001 andM002
are families 1 and 2, respectively, as described in Storm et al.5
aProband has a similarly affected sibling and mildly affected father with the same mutation.37
bIP, incomplete penetrance.average of ~22,000 total variants, with a final-pass filter
set of ~18,900 variants annotated for variant function
(i.e., missense, synonymous, splicing, insertion or deletion
[in/del], etc.) (Genome Variation Server).
Given the consistency among the phenotypic features,
we first analyzed exome data from all five probands to
identify any genes with novel variants shared among
them. Proband variant data (i.e., missense, in/dels, and
splice acceptor and donor sites) were initially filtered
against a smaller database of ~1,200 control exomes drawn
from a subset of individuals from the National Heart, Lung,
and Blood Institute (NHLBI) Exome Sequencing Project
(ESP) to identify novel variants, those passing GATK
filtering, and those evident at a robust coverage level
(>20x). Second, we performed discrete filtering to identify
any gene in which all probands shared novel missense,
insertion/deletion, nonsense, or splice variants consistent
with either an autosomal-dominant or -recessive model.
Under these models and criteria, no genes were detected
in common between all probands.
We expanded our search for de novo mutations in
probands (S001, S004, and S008), using data from parental
individuals along with stringent parameters for GATK pass
filters and a sequence depth of >203 in both parents and
probands. This identified six putative genes (ASPSCR1,
C2orf16, HERC1, PAIP1, PLCB4, and TCHP) within these
three individuals. The PLCB4 (MIM 600810) variant
c.1868A>G (NM_000933.3; p.Tyr623Cys) had the highest
conservation Genomic Evolutionary Rate Profiling
(GERP)20,21 score (6.17) and was considered the top candi-
date on the basis of the core signaling role of its ortholog
plcb3 in mandibular patterning of zebrafish.22,23 Sanger
sequencing of parents S002-P and S003-P (kindred B, indi-
viduals I-1 and I-2 in Figure S1) and the proband (S001)
confirmed it as a de novo mutation (Table 1). On the basis
of this finding, we searched the remaining proband exome
data for additional PLCB4 variants and identified, in
siblings S004 and S005, a second missense mutation at
c.986A>C, which changed the amino acid at position 329
from asparagine to serine (p.Asn329Ser; Table 1). In thisThe Amkindred, the mutation was transmitted from the mildly
affected father (S006-P [kindred A, individual I-1 in
Figure S1]), a transmission which supports the variable
expressivity of ACS.
The discovery of putative coding-sequence, disease-
causing PLCB4 mutations in isolated ACS kindreds led us
to use Sanger sequencing to screen the gene coding regions
containing the conserved catalytic site (exons 11–26) in
two additional multigeneration ACS pedigrees5 (family 1
[M001] and family 2 [M002] in Figure S2). We identified
two additional novel PLCB4 missense mutations at
c.1862G>A (M001) and c.1948A>C (M002) (with resul-
tant protein changes, p.Asn650His and p.Arg621His,
respectively) that segregated in affected individuals (Table 1
and Figure S2). We have also identified a family with an
ACS proband (family 3 [M003], individual IV-1 in Fig-
ure S2; with micrognathia, cleft palate, glossoptosis, and
a constriction between the helix and the lobule of the
left ear) and his ‘‘unaffected’’ father (individual III-1) who
presented with asymmetric ear lobes. The family history
is significant for four paternal relatives with ear malforma-
tions with or without micrognathia (Table 1; family 3 in
Figure S2). Sanger sequencing confirmed a PLCB4missense
mutation at c.1862G>A (p.Arg621Cys) in the proband
and his unaffected father, the same amino-acid position
(621) as noted in family M001 but a different amino-acid
change. The phenotypic variability of ACS in these families
was confirmed by the variable expressivity and apparent
incomplete penetrance associated with the father (S006-
P) of a proband with a PLCB4 mutation.5 None of the
PLCB4mutations we discovered had been identified previ-
ously in a large set of control exomes containing 10,758
chromosomes (Table 1). Each of the mutations led to
substitutions at highly conserved nucleotide positions
(those with a GERP score > 5.8 make up the top 0.006%
of coding nucleotides21) and evolutionary invariant
amino-acid positions (Figure 3).
Discrete filtering of exome data from the PLCB4-muta-
tion-negative probands (S008, S011, and A001) revealed a
Sanger-confirmedsingle-missensemutation inan inhibitoryerican Journal of Human Genetics 90, 907–914, May 4, 2012 909
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Figure 3. Conservation and Substitution Modeling of PLCB4
and GNAI3
(A) PLCB4 sequence alignment at the highly conserved
catalytic domains. Alignments were performed between human,
Drosophila, and fungus protein sequences with the use of
ClustalW2. Conservation among vertebrates, invertebrates, and
fungi suggests evolutionary importance for these residues. Identi-
fied substitutions are depicted in green boxes; residues conserved
between humans, Drosophila, and fungi are depicted in yellow;
conservative substitutions are in orange; and divergent residues
are in white. Protein sequences used for alignment of PLCB4
include Homo sapiens (NP_877949.2), Drosophila (no receptor
potential A, isoform D, NP_001014720.1), and Aspergillus clavatus
NPRL 1 (1-phosphatidylinositol-4,5-bisphosphate phosphodies-
terase 1 [XP_001268930.1]).
(B) Sequence alignment (similar to panel A) of the GNAI3 catalytic
region with the p.Gly40Arg ACS subsitution. Protein sequences
used for alignment of GNAI3 include Human (NP_006487.1),
910 The American Journal of Human Genetics 90, 907–914, May 4, 2G protein (GNAI3; MIM 139370) in exon 1 (c.118G>C
[NM_006496.2; p.Gly40Arg]) shared by individuals S008
and S011 (Table 1). In both kindreds, the p.Gly40Arg
variant was inherited; in one case (S011) it was inherited
from an affected mother (S012-P), and in the other (S008),
from an unaffected father (S009-P), documenting incom-
plete penetrance. Using the exome data, we confirmed that
these individuals did not share a haplotype region encom-
passing this mutation, and all other measures of global
genomic relatedness, determined by analyzing all exome
variants or specific high-frequency variants, were consistent
with unrelatedness. These data suggest the possibility of
a recurrent mutation at this position. The p.Gly40Arg
substitution also was not observed in 10,758 control chro-
mosomes, and it occurred at a highly conserved amino-
acid residue (and the Grantham score [125] suggested a
moderately radical amino-acid replacement24) within the
guanosine diphosphate (GDP)-binding catalytic domain
of this G protein (Table 1; Figure 3). Furthermore, GNAI3
maps in the vicinity of the region on chromosome 1 previ-
ously linked with the ACS phenotype.6 Given this, we
considered the GNAI3 p.Gly40Arg change to be an ACS
candidate because of the known role of phospholipase C
(PLC) in G protein-coupled receptor signaling, a core com-
ponent of the endothelin-DLX pathway14 (reviewed in
Clauthia et al.25).
To further evaluate the significance of variants in PLCB4
(p.Asn329Ser, p.Arg621His, p.Arg621Cys, p.Tyr623Cys,
p.Asn650His) and GNAI3 (p.Gly40Arg), we performed
detailed structural protein modeling of specific substitu-
tions found in ACS probands. All missense variants ob-
served in cases, controls, and accessible databases were
mapped to PLCB4 and GNAI3 protein structures and
visualized with UCSF Chimera.26 None of the variantsDrosophila (G protein ai subunit 65A, NP_477502.1), and Saccharo-
myces cerevisiae (Gpa2p, NP_010937.1).
(C) PLCB4 structure depicting the four missense substitutions
(red residues). In this panel and in panel E, othermissense variants
observed in controls are shown as light gray spheres.
(D) Magnification of the active site of PLCB4 demonstrates variant
residues that contribute directly to catabolic release of inositol
triphosphate (IP3, gray molecule) and disrupt catalytic function
without destabilizing protein folding. These residues are presumed
to inhibit MAPK signaling without affecting other protein interac-
tions. Calcium ion is depicted in purple. Hydrogen bonds between
amino-acid side chains, calcium ion, and IP3 are shown as blue
lines, and ionic metal bonds are shown as green dashed lines.
(E) GNAI3 structure showing the p.Gly40Arg mutant (red) residue.
(F) Magnification of the GNAI3 active site shows the Gly40Arg
mutant residue (pink lines) reaching across a previously unde-
scribed cavity (transparent green), consistent in all three GNAI3
crystal structures, to stabilize the RapGapII-recognized active con-
formation of guanosine triphosphate-activated switch III (black
ribbon; switch I in gray ribbon, switch II in white ribbon) by form-
ing a hydrogen bond network (pink lines) between the Gly40Arg
residue, a nearby main chain carbonyl (blue ribbon), and stabi-
lizing the active confirmation of switch III through interaction
with the key switch residues (red and white sticks). Switch III is
recognized by RapGapII and would lead to inhibition of the
MAPK pathway activation through Rap (Figure 4).
012
identified in controls occurred in the catalytic domains of
these highly conserved proteins.
In PLCB4, modeling each mutated side chain resulted in
minimal overall structural impact27 but removed hy-
drogen and ionic bonds essential to the catalysis of phos-
phatidylinositol 4,5-bisphosphate into inositol 1,4,5-
trisphosphate and diacylglycerol (Figures 3C and 3D).
Thus, these ACS-associated PLCB4 substitutions are local-
ized within the PLCB4 catalytic substrate binding domain
(Figure 3D) and would be expected to directly affect
function.
The GNAI3 p.Gly40Arg variant side chain was modeled
with each of the three currently available GNAI3 struc-
tures.28,29 Effects of the substitution on GNAI3 stability
were measured with multiple knowledge-based scoring
functions.27 Minimal to positive influence on stability sug-
gested further study and led us to examine why this large
arginine substitution was tolerated in the conserved core
of the G-alpha protein.27 A detailed assessment30 revealed
a cavity large enough for an organic cationic metabolite in
each of the three crystal structures (Figures 3E and 3F, semi-
transparent green surface) and large enough to hold and
electrostatically balance the guanidinium group. Our pro-
tein modeling suggested the presence of hydrogen bonds
between the Arg40 side-chain nitrogens and (1) the
P loop Gly42 backbone carbonyl, (2) the Asp229 side
chain, and (3) the Ser246 side chain (Figure 3F, pink lines).
Modeling the p.Gly40Arg variant suggests stabilization of
GNAI3 in the active conformation (switch III).25 Examina-
tion of potential interactions with the downstream sig-
naling partner RapGAPII through analysis of the common
structural fold between Rap and GNAI331 revealed close
recognition of the constitutively activated switch III.
Thus, modeling the GNAI3 p.Gly40Arg substitution
suggests a gain of function, with stabilization of the active
conformation recognized by RapGapII triggering inhibi-
tion of the mitogen-activated protein kinase (MAPK) path-
way activation through Rap.
As a proxy for assessing the effects of the substitution on
GNAI3 activity, we chose to assay the expression of two
known downstream targets of the G protein-coupled endo-
thelin receptor pathway, DLX5 and DLX6, which play
a key role in mandibular patterning.12–15 The importance
of PLC and G protein signaling in this pathway led us to
hypothesize that a potential dominant-negative effect of
PLCB4 mutations and a gain-of-function GNAI3 mutation
would lead to downregulation of DLX5 and DLX6. We
measured gene expression levels for DLX5 and DLX6 in
available cultured mandibular osteoblasts from our two
GNAI3 probands (p.Gly40Arg), one PLCB4 proband
(p. Try623Cys), and one unresolved ACS proband (A001).
Using quantitative, real-time RT-PCR of steady-state
mRNA, we identified a 6-fold reduction of DLX5 (p <
0.005; probands versus controls) and an 8-fold reduction
of DLX6 expression (p < 0.001) in mandibular osteoblasts
from selective probands relative to 17 randomly selected
calvarial osteoblasts from controls. Preliminary RNAThe Amsequencing experiments showed similar and relatively
strong levels of expression of PLCB4 and GNAI3 in control
calvarial osteoblasts (data not shown), and at levels 2–4
fold greater than DLX5 and DLX6. These data support
a final common pathway leading to DLX5/6 regulation
through suppression of the endothelin pathway as a
unifying cause. These data also provide a basis for exam-
ining other candidate genes with similar functional effects
in our single unresolved case (A001), negative for muta-
tions in PLCB4 and GNAI3. To do this we looked at our
initial exome results for A001 to identify singleton exon
sequence variants in candidate genes from the PLC gene
family (PLCD1, PLCXD1, PLCH1), PLC pathway candidate
genes (PI4KA, DOCK1, DOCK6, MIOX, HRASLS, RAC1),
or known endothelin-DLX5/6 pathway genes (BMPER,
IGF2BP2, WNT7A). Although sequence variants were
detected in five candidate genes (from the list above),
upon the application of information from our large control
set, only DOCK1 and DOCK6 sequence variants were not
present in controls (Table S1). As members of the DOCK-C
subfamily of the DOCK family of guanine nucleotide
exchange factors, both genes have a suggestive function
as an activator of small G proteins.32 Although we are hesi-
tant to draw conclusions from a single proband without
parental data, it is intriguing to have identified an excep-
tionally rare mutation in a G protein activator in a disorder
known to be caused by disruption of signaling through a G
protein-dependent signaling pathway. Further functional
studies will be required to test the putative role of
these DOCK-related genes in the endothelin-DLX5/DLX6
pathway and mandibular patterning.
Our primary observation of a de novo mutation in
PLCB4 led us to identify other mutations in a second
kindred and in three confirmatory pedigrees. Further
analysis of PLCB4-negative probands identified a second
(GNAI3) mutation in two probands and aDOCK6 sequence
variant in another proband, indicating a role for endothe-
lin-1 pathway genes in this heterogeneous condition. In
each of the families with transmission of the PLCB4
or GNAI3 mutations, we observed incomplete penetrance
and/or variable expressivity of the ACS phenotype.
Although variable expression is common among domi-
nant craniofacial disorders, the nature of phenotypic vari-
ability in ACS suggests that common craniofacial dis-
orders such as micrognathia, Pierre Robin sequence (MIM
261800), and microtia may also be caused by mutations
in this pathway.
The interpretation of our data was supported by knowl-
edge of classic developmental model systems. In zebrafish,
mutations in edn1 result in a reduction in lower jaw size
and fusion to dorsal structures with loss of the intervening
joints.25,33,34 Mutations of schmerle (she), the zebrafish
ortholog of PLCB3 (and ortholog of PLCB4), result in a
near phenocopy of edn1 mutations, with reduction of the
ventral facial skeleton and fusion to dorsal skeletal
elements.22 Two she alleles have been identified in the
highly conserved catalytic domains of plcb3, the sameerican Journal of Human Genetics 90, 907–914, May 4, 2012 911
Figure 4. Hypothesized Pathway for Mandibular Patterning
Associated with Mutations in the Endothelin-DLX5/6 Pathway
Several reports support the premise that mutations in the endo-
thelin pathway cause homeotic transformation of the lower
(ventral) jaw to a maxillary (dorsal) identity. Mutations in mice
of Edn1, Ednra, the G protein aq subunit, Dlx5/Dlx6, and most
recently Hand2, each result in a small ventral jaw with dorsal
jaw features. Mutations in zebrafish plcb3 lead to the same home-
otic transformation. In this figure, cartoons of fish, mice, and
humans indicate gene family members in this pathway that,
when mutated, result in a homeotic transformation of the dorsal
and ventral jaws (left: PLCB4 loss-of-function, right: GNAI3 gain-
of-function). The arrow with a dashed line indicates hypothetical
signaling between aq and PLCB4. Figure adapted from Marinissen
and Gutkind.45domains in which we have defined substitutions in PLCB4.
she is required for edn1-dependent dlx5a, dlx6a, and dlx3a
expression. Furthermore, when plcb3/ neural crest cells
were transplanted into wild-type embryos, they con-
tributed to dorsal, but not ventral or intermediate, jaw
structures, suggesting that plcb3 may be necessary for the
determination of ventral branchial arch fates and func-
tions downstream of edn1. In another animal model,
knockdown of PLCB3 in Xenopus results in reduction of
cartilage in the first pharyngeal arch and loss of the jaw
joint, in a proportion of treated embryos.35 The lack of
a craniofacial phenotype in the Plcb4 knockout mouse36
suggests that the catalytic domain substitutions identified
in our cases and in zebrafish schmerle may result in domi-
nant negative effects.37 A similar mechanism has been sug-
gested for a splice variant affecting the catalytic domain of
PLCD4, which has a dominant negative effect on the func-
tion of other wild-type PLC enzymes.38 Although studies
to confirm this hypothesis are necessary, these data would
suggest that the loss of PLC catalytic function, in the
absence of effects on protein stability, may confer domi-
nant negative effects.
The observed conversion from a mandibular to a maxil-
lary phenotype, as we have described for ACS, represents
a homeotic transformation and is supported by several
mouse knockout models (Ednra39 and Edn140 annotated
in Figure 4). Mice with targeted mutations of endothelin-
converting enzyme 1 (Ece-1), Edn1, Ednra, and G protein
alpha subunits (Gaq, Ga11) each exhibit a reduction in
ventral jaw size and fusion to dorsal skeletal compo-
nents.13,14,40–43 Similarly, mice lacking expression of Dlx5912 The American Journal of Human Genetics 90, 907–914, May 4, 2and Dlx6 demonstrate transformation of the lower jaw
into an upper jaw phenotype.13,15,16,25 This homeotic
transformation was the first described in any gene other
than the classic Hox genes.15 Furthermore, selective reduc-
tion of another member of the endothelin-Dlx5/Dlx6
pathway, Hand2, in the cranial neural crest results in
duplication of palatine bones in the mouse mandible and
aglossia.44 These findings support a role for Edn1-Dlx5/
Dlx6 as a prototypical signaling pathway (Figure 4) in
cranial neural crest cell proliferation in the first branchial
arch that is necessary for mandibular specification. As
described above, this pathway is further supported by our
quantitative real-time PCR analysis in osteoblasts from
four ACS cases, which demonstrates a significant reduction
in the downstream expression of DLX5 and DLX6
(Figure S3).
We report the identification of extremely rare, highly
conserved mutations (both de novo and inherited) in
two endothelin pathway signaling enzymes, PLCB4 and
GNAI3, as the molecular causes of ACS and further define
the role of the endothelin-distal-less pathway in the spec-
ification and patterning of the lower jaw of vertebrates.
The ACS phenotype is consistent with the transforma-
tion of the mandible to a maxillary identity and consti-
tutes a molecularly defined homeotic transformation in
humans. The phenotypic variability of ACS suggests that
mutations in this pathway, especially those affecting core
signaling molecules such as PLCB4 and GNAI3, should
be considered as potential candidates for other ear and
jaw malformations. The identification of phenotypic vari-
ability and incomplete penetrance underscores the utility
of these results in genetic counseling of families affected
by ACS.Supplemental Data
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